Samrudh Pharmaceuticals
India-based pharmaceutical manufacturer established in 1993 focused on sterile injectable production for human and veterinary markets, with multiple production units, in-house analytical laboratories, contract manufacturing/technology transfer capability, and export approvals for international markets.
Industries
Nr. of Employees
medium (51-250)
Samrudh Pharmaceuticals
Products
Human injectables
Sterile injectable formulations produced as ampoules, multi-dose vials and dry powder injectables.
Veterinary injectables
Sterile injectable products manufactured for veterinary applications.
Ointments and suppositories
Topical and suppository dosage forms produced at an associated plant.
Human injectables
Sterile injectable formulations produced as ampoules, multi-dose vials and dry powder injectables.
Veterinary injectables
Sterile injectable products manufactured for veterinary applications.
Ointments and suppositories
Topical and suppository dosage forms produced at an associated plant.
Services
On-site contract manufacturing services for pharmaceutical companies with ability to accept and adapt client technology transfers for sterile injectable products.
On-site contract manufacturing services for pharmaceutical companies with ability to accept and adapt client technology transfers for sterile injectable products.
Expertise Areas
- Sterile injectable manufacturing
- Cephalosporin drug production
- Contract manufacturing and technology transfer
- Quality control and analytical testing
Key Technologies
- Sterile filling and sealing for ampoules and vials
- Dry powder injectable formulation and filling
- Microbiology laboratory testing
- Chemical analytical testing
News & Updates
One production unit (Unit-III) is stated as E.U.-approved (Romania).
Company reports export presence and approvals across numerous countries in the Middle East, Africa, Latin & Central America, South East Asia, Europe and CIS regions.
One production unit (Unit-III) is stated as E.U.-approved (Romania).
Company reports export presence and approvals across numerous countries in the Middle East, Africa, Latin & Central America, South East Asia, Europe and CIS regions.